Driving interdisciplinary science to transform the understanding and control of infection.
Despite incredible progress, infectious diseases remain a threat that affects populations worldwide. Outbreaks with pandemic potential such as COVID-19 and SARS have had profound health, social and economic impact on the world. Meanwhile, endemic and epidemic diseases such as malaria, influenza and tuberculosis still claim the lives of millions. On top of the looming threat of the future emerging infections, the spread of drug resistance means that once-treatable infections require new solutions.
These challenges need urgent tackling. The question is: ‘how?’
At Imperial, we know the answer lies in interdisciplinary collaboration, and are known for applying this approach effectively to global challenges. Building on these foundations, Imperial’s Institute of Infection is uniting clinical, medical, engineering, natural science and economic experts to transform the way infection is studied, taught and mitigated around the world. With the help of supporters, friends and alumni like you, we can realise its full and exciting potential.
Through the Institute of Infection, we are breaking down traditional departmental silos, instead, training and empowering researchers to work at the interface of their fields, which is where the solutions to our current and future infection challenges lie. We are connecting and growing a powerful network operating across specialties, industries and borders to turn fundamental discoveries into interventions that will save and improve lives.
Find out more in our introduction to the Institute of Infection.
Our four priority areas
Understanding infection
We will better understand infection through fundamental scientific research. We will use cell biology, structural biology and the biology of the infectious agent to examine the ways that infections from viruses, bacteria, fungi or parasites develop as well as the immune responses and human physiology they provoke.
Finding infection
We will transform the way we find infection by harnessing Imperial’s unique strengths in molecular biology, bioengineering and technology development to create faster, more sensitive and more affordable diagnostic tests for better surveillance and early intervention.
Priorities 2
Treating infection
We will treat infections better by rationalising antibiotic use, as well as by developing new antimicrobials, antivirals and treatments for chronic infections, improving healthcare for both individuals and populations. Strong collaborations with our partner NHS trusts underpin this, and we are currently working with Imperial College Healthcare in particular to expand capability in clinical infection research through the proposed Fleming Centre for Clinical Infection Research.
Preventing infection
We will help prevent infection by integrating our institutional expertise across epidemiology, molecular biology, data analytics and clinical trials to drive the discovery of new vaccine targets, technologies, manufacturing and distribution methods, for current and future disease threats.
Becoming a donor
We’d love to tell you more and answer any questions you have about the Institute of Infection. To discuss how your generosity can make a difference, please get in touch:
Contact
-
Rowena Morgan
/prod01/channel_3/media/images/people-list/Rowena-Morgan--tojpeg_1563528148184_x4.png)
Personal details
Rowena Morgan Deputy Director of Development, MedicineSend email+44 (0)7525 313 712